EcoDrugPlus

Ribosomal Protein S7

Ensembl ID : ENSATEG00000027580
Gene Symbol: RPS7
3 Cross references
370 Possible Orthologues:

Ribosomal Protein S8a

Ensembl ID : ENSATEG00000018166
Gene Symbol: RPS8A
2 Cross references
327 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSATEG00000022661
Gene Symbol: RPS9
2 Cross references
237 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSATEG00000011829
Gene Symbol: RPSA
3 Cross references
516 Possible Orthologues:

Ribosomal Protein, Large, P0

Ensembl ID : ENSATEG00000023848
Gene Symbol: RPLP0
2 Cross references
403 Possible Orthologues:

Ribosomal Protein, Large, P1

Ensembl ID : ENSATEG00000012174
Gene Symbol: RPLP1
2 Cross references
386 Possible Orthologues:

Selectin E

Ensembl ID : ENSATEG00000004135
Gene Symbol: SELE
1 Cross references
181 Possible Orthologues:

Selectin P

Ensembl ID : ENSATEG00000004083
Gene Symbol: SELP
1 Cross references
170 Possible Orthologues:

Serpin Peptidase Inhibitor, Clade C (Antithrombin), Member 1

Ensembl ID : ENSATEG00000005938
Gene Symbol: SERPINC1
2 Cross references
201 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSATEG00000026784
Gene Symbol: SIGMAR1
3 Cross references
205 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSATEG00000016777
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 10

Ensembl ID : ENSATEG00000005946
Gene Symbol: SCN10A
1 Cross references
245 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).